Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database

Abstract

In a very large observational study, the use of DPP-4i was associated with a reduced risk of HHF when compared with sulphonylureas.